Regulatory Affairs Consulting Firm

SIMPLIFY YOUR MARKET APPROVAL

Medical Devices | Cosmetics | Dietary Supplements

The Mexican market is complex and diverse, so it's essential to have a tailored strategy for each product.

IPS is a leading provider of regulatory services for the health industries in Mexico. We help manufacturers and distributors of medical devices, dietary supplements, and cosmetics navigate the complex Mexican regulatory landscape. Contact us today to learn more.

 

IPSNews

Featured
Storage and distribution of dietary supplements under NOM-251-SSA1-2009
IPS, COFEPRIS, Dietary Supplements, Regulatory Framework
Storage and distribution of dietary supplements under NOM-251-SSA1-2009
IPS, COFEPRIS, Dietary Supplements, Regulatory Framework

In the dietary supplement industry, storage is not merely the safeguarding of merchandise; it is a vital link in the value chain that guarantees the safety and efficacy of the final product. For distribution companies in Mexico, compliance with NOM-251-SSA1-2009 is both a legal and ethical obligation.

IPS, COFEPRIS, Dietary Supplements, Regulatory Framework
RAUpdate Primera Resolución de modificaciones a las RGCE para 2026: Prórroga de la MVE y precisiones técnicas
IPS, Logistics, VUCEM
RAUpdate Primera Resolución de modificaciones a las RGCE para 2026: Prórroga de la MVE y precisiones técnicas
IPS, Logistics, VUCEM

El pasado 30 de marzo de 2026, el Sistema de Administración Tributaria (SAT) publicó de manera anticipada la primera resolución de modificaciones a las Reglas Generales de Comercio Exterior del año, la cual oficializa una prórroga para la entrada en vigor de la Manifestación de Valor Electrónica (MVE) hasta el 31 de mayo de 2026.

IPS, Logistics, VUCEM
RAUpdate: Creation of the CENAFyT and its impact on the health sector.
COFEPRIS, Regulatory Framework, Post market surveillance
RAUpdate: Creation of the CENAFyT and its impact on the health sector.
COFEPRIS, Regulatory Framework, Post market surveillance

On March 9, 2026, COFEPRIS officially announced the creation of the National Center for Pharmacovigilance and Technovigilance (CENAFYT). This body emerges not as an isolated entity, but as the strategic evolution of the former National Pharmacovigilance Center (CNFV), following the legal modifications made to the General Health Law at the beginning of 2026.

COFEPRIS, Regulatory Framework, Post market surveillance

Upcoming Events

Featured
AMIC DENTAL
May 6
World Trade Center
AMIC DENTAL
World Trade Center
World Trade Center
INTERNATIONAL MEDICAL EXPO
May 25
Expo Guadalajara
INTERNATIONAL MEDICAL EXPO
Expo Guadalajara
Expo Guadalajara
ADLM 2026
Jul 26
Convention Center Anaheim
ADLM 2026
Convention Center Anaheim
Convention Center Anaheim